BIOXYTRAN, INC. Convertible Notes Payable, Current
BIOXYTRAN, INC. (BIXT) had Convertible Notes Payable, Current of $805.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Notes and Loans Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-08-14
- 2026-06-30: Convertible Notes Payable, Current $805.00K.
- 2026-03-31: Convertible Notes Payable, Current $805.00K.
- 2025-12-31: Convertible Notes Payable, Current $805.00K.
- 2025-09-30: Convertible Notes Payable, Current $805.00K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-06-30 | $805.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $805.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $805.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $805.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $805.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $805.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $805.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $805.00K 10-Q · filed 2024-10-29 |
| 2024-06-30 | $730.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $861.50K 10-Q · filed 2024-04-19 |
| 2023-12-31 | $1.90M 10-K · filed 2025-04-03 |
| 2023-09-30 | $1.90M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $2.00M 10-Q · filed 2023-07-31 |
| 2023-03-31 | $2.17M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $2.17M 10-K/A · filed 2025-01-13 |
| 2022-09-30 | $2.16M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $3.59M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $3.55M 10-Q · filed 2022-05-23 |
| 2021-12-31 | $2.12M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.09M 10-Q · filed 2021-11-17 |
| 2021-06-30 | $1.06M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.61M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.61M 10-K · filed 2022-04-11 |
| 2020-09-30 | $1.60M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $1.60M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $1.72M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $850.98K 10-K · filed 2021-04-09 |
| 2019-09-30 | $589.28K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $633.21K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $742.69K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $227.38K 10-K · filed 2020-03-18 |